- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2618EUR$2,950USD£2,262GBP
- Report
- September 2023
- 112 Pages
Europe
From €3062EUR$3,450USD£2,645GBP
- Report
- September 2023
- 194 Pages
Global
From €4393EUR$4,950USD£3,796GBP
- Report
- November 2022
- 160 Pages
Global
€3018EUR$3,400USD£2,607GBP
- Report
- February 2021
- 80 Pages
India
From €1056EUR$1,190USD£912GBP
- Report
- July 2018
- 224 Pages
Global
From €1598EUR$1,800USD£1,380GBP
- Drug Pipelines
- January 2018
- 13 Pages
Global
From €8875EUR$10,000USD£7,668GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,224USD£3,130GBP
- Report
- January 2025
- 85 Pages
Global
From €3500EUR$4,224USD£3,130GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,224USD£3,130GBP
- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£728GBP
- Report
- November 2023
- 102 Pages
Global
From €1331EUR$1,500USD£1,150GBP
- Report
- November 2024
- 90 Pages
Australia
From €1650EUR$1,859USD£1,425GBP
- Book
- February 2025
- 432 Pages
- Book
- August 2012
- 552 Pages

The Immunization market is a subset of the Vaccines market, which is focused on the development, production, and distribution of immunization products. Immunization products are designed to protect individuals from infectious diseases, such as measles, mumps, rubella, and polio. These products are typically administered through injections, but can also be administered orally or nasally. Immunization products are typically developed by pharmaceutical companies, and are then distributed to healthcare providers and pharmacies.
The Immunization market is highly regulated, with governments and health organizations setting standards for the production and distribution of immunization products. Additionally, governments and health organizations often provide funding for immunization programs, which can help to increase access to immunization products.
Some companies in the Immunization market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more